SIU-SOM |About SIU-SOM|Directories|News & Information|SIU-Carbondale|Search
Fellowship|Residency|Research Interests|The Cancer Institute|The Breast Center| The Trauma Center | The Cutting Edge

Curriculum Vitae

Edward J. Alfrey, M.D.
Professor and Chairman of the Division of Surgery

Office Address:   Department of Surgery
Southern Illinois University School of Medicine
P.O. Box 19638
Springfield, IL. 62794-9638
email: ealfrey@siumed.edu

Specialities

  • Hepatobiliary Surgery
  • Liver/kidney Transplant Surgery

Brief Biography

Dr. Edward Alfrey is Professor and Chairman of the Division of Surgery at Southern Illinois University School of Medicine.  He is fellowship trained in liver, pancreas, and kidney transplantation.  His practice includes general surgery and he has a special interest in hepatobiliary surgery, particularly regarding tumors of the liver and complex biliary reconstruction.  He also specializes in kidney/pancreas transplantation.

Prior to joining SIU, Dr. Alfrey was at the Pennsylvania State University School of Medicine, Stanford University School of Medicine and the University of Pennsylvania School of Medicine.  He is certified by the American Board of Surgery.  His professional affiliations include the American College of Surgeons, American Society of Transplantation, the American Association for the Study of Liver Disease, and American Association of Immunologists. 

Dr. Alfrey earned his bachelor’s from the University of Denver and his medical degree from the University of Colorado.  He received his residency training from the University of Arizona in Tucson and served a fellowship in transplantation at the Hospital of the University of Pennsylvania, in Philadelphia, Pennsylvania.  He recently completed a master’s degree in Health Care Management from Harvard University in Boston. 

Dr. Alfrey has published numerous articles and book chapters and has multiple research interests including liver transplant immunology, renal physiology, and clinical outcomes.  For more information or to schedule an appointment with Dr. Alfrey, please call SIU Physicians and Surgeons at 217-545-5878

Education and Post Graduate Training

  • September 1972- June 1976 B.A. University of Denver (Chemistry)
  • August 1980- May 1984 M.D. University of Colorado
  • August 2003- June 2005M.S. Harvard University (Health Care Management)

Postgraduate Training

                                   
  • July 1984-June 1985 Intern in Surgery, University of Arizona, Tucson
  • July 1985-June 1988 Resident in Surgery, University of Arizona, Tucson
  • July 1988-June 1989 Chief Resident in Surgery, University of Arizona, Tucson
  • July 1989-June 1990 Clinical Fellow in Transplantation, Hospital of the University Pennsylvania, Philadelphia.
  • July 1990- June 1991Research Fellow in Immunobiology, Harrison Department of Surgical Research; Principal Investigators, Drs Clyde Barker and Ali Naji, University of Pennsylvania, Philadelphia.
  • September 1999 Advanced Laporoscopic Surgery, Lawrence Way, University of California, San Francisco.          
  • October 2002 Leadership Development for Physicians in Academic Health Centers.  The Harvard School of Public Health.

Faculty Appointments

  • July 1989- June 1991 Instructor in Surgery, Department of Surgery, University of Pennsylvania, School of Medicine
  • August 1991- May 2000 Assistant Professor of Surgery, Department of Surgery, Stanford University School of Medicine
  • May 2000- July 2005 Associate Professor of Surgery with Tenure, Department of Surgery Pennsylvania State University School of Medicine
  • August 2005 Professor of Surgery, Department of Surgery Southern Illinois University, School of Medicine

Licensure

  • California  G72742

  • Pennsylvania  MD044014E

  • Illinois  36114340

Certification

  • American Board of Surgery 2/94 38911
    Re-certified 10/03   45357
  • National Board of Medical Examiners 302102

Awards, Honors and Memberships in Honorary Societies

  • Pioneer Award, University of Denver, 1976
  • Outstanding Achievement in Resident Research, University of Arizona,1989
  • Cum Laude Award for the Outstanding Scientific Paper, Society of Body Tomography and Magnetic Resonance, 1994
  • Kaiser Award for Excellence in Clinical Teaching, Stanford University, 1997
  • Franklin G. Ebaugh Jr. Award for Advising Medical Students, Stanford University, 1997
  • Arthur L. Bloomfield Award for Excellence in Teaching Clinical Medicine, Stanford University, 1998

Society Memberships

  • American College of Surgeons, Fellow
  • American Association for the Study of Liver Disease
  • American Association for the Advancement of Science
  • American Association of ImmunologistsAmerican Hepato-Pancreato-Biliary Association
  • American Medical Association
  • American Society of Transplantation
  • American Society of Transplant Surgeons
  • Association for Academic Surgery
  • Clinical Immunology Society
  • International Liver Transplantation Society
  • International Pediatric Transplant Society
  • San Francisco Surgical Society
  • Southwest Surgical Congress, Fellow
  • Society of University Surgeons
  • The Transplantation Society

Major Teaching and Clinical Responsibilities for Stanford

  • Attending, Transplant Surgery, 1991-2000
  • Attending, Trauma Surgery, 1992-95
  • Director, Student Core Clerkship, Surgery 300A, 1995-2000
  • Course Director, Transplantation Science, Surgery 225, elective for medical students, 1992-1999
  • Co-Director, Resident Core Course in Surgical Science, 1992-95
  • Faculty Preceptor, Surgical Journal Club, 1992-95
  • Faculty Preceptor, Department of Surgery Resident Research Conference, 1992-95
  • Medical Student Mentor Program, 1992-97
  • Freshman Advisor Program, 1993-97
  • Faculty Advisor for Research, Early Matriculation Program 1994, 1995, 1997, 1999

Administrative Resopnsibilities for Stanford

Acting Director, Adult Kidney and Kidney /Pancreas Transplantation 9/98-3/99

 

Committee, Other Responsibilities at Stanford

  • Admissions Panel, Stanford Medical School, 1992-97
  • Ad Hoc Grant Reviewer for OTL Research Initiative Fund Grants, 1992
  • Senator, University Faculty Senate, 1996-98
  • Senator, Medical School Faculty Senate, 1997-2000

Administrative Resopnsibilities for Penn State Chief, Division of Transplant Surgery, 5/00 ? 6/05Administrative Resopnsibilities for Southern Illinois University Chair, General Surgery, 8/05 - present Other Professional Responsibilities:

  • Ad Hoc manuscript reviewer, The Journal of Surgical Research
  • Ad Hoc grant reviewer, The Department of Veterans Affairs
  • Ad Hoc manuscript reviewer, The American Journal of Transplantation
  • Ad Hoc manuscript reviewer, Pediatric Nephrology
  • Region 5 Representative to the Pediatric Committee, United Network for Organ Sharing (1996-1998).
  • Vice Councilor, Southwestern Surgical Congress (1998-2001).
  • Medical Director, California Transplant Donor Network (1999-2000).
  • Bylaws Committee, American Society of Transplant Surgeons (1998-2000).
  • Board of Directors, Gift of Life Organ Procurement Organization (2000-present)
  • Co-Chair, Organ Donation Committee, American Society of Transplantation (2000-     2001).
  • Renal Transplant Training Committee, American Society of Transplantation (2001- present).
  • Membership Committee, American Society of Transplant Surgeons (2001-2003)
  • Ad Hoc Membership Database Committee, American Society of Transplant Surgeons (2003- present).
  • Co-Chair, Abstract Review Committee on Clinical Science, Transplant 2002.
  • U.S. Department of Health and Human Services, Grant Peer Review Panel, Clinical Interventions to Increase Organ Procurement, 8/02
  • Co-Chair, Abstract Review Committee on Clinical Science, Transplant 2004.
  • U.S. Department of Health and Human Services, Grant Peer Review Panel, Clinical Interventions to Increase Organ Procurement, 6/04.
  • Co-Chair, Abstract Review Committee on Clinical Science, ATC-Transplant 2005.

Invited Session Chair

  • Kidney Transplantation: Non-heart beating donors. The International Congress of the Transplantation Society, Rome, Italy, 8/22/00.
  • Kidney Transplantation; AST/ASTS consensus conference, ?Maximizing the use of organs recovered from cadaveric donors; Washington, D.C., 3/28-3/29/01.
  • Paid Donors. American Transplant Congress, Washington DC, 5/02.
  • Kidney: Outcome II. American Transplant Congress, Washington DC, 5/02.
    The use of expanded criteria donor kidneys. American Transplant Congress, Boston, MA. 5/04
  • Organ donation, allocation, preservation: Kidney. American Transplant Congress 2005. 5/22/05
  • Donation and allocation. American Transplant Congress 2005. 5/23/05

Community Service

  • Boys basketball coach, YMCA, 1997, 1998, 1999, 2000
  • Girls basketball coach, YMCA, 1998, 1999, 2000

Grant Support

  • Prolongation of Xenografts Following Intrathymic Antigen Inoculation. OTL Research Initiative Grant, Stanford University; PI, 5/93-5/94, $25,000 direct costs
  • Strategies for Immune Tolerance in Monkeys. OTL Research Initiative Grant, Stanford University; PI, 5/94-5/95, $25,000 direct costs.
  • Anti-CD2 Monoclonal Antibody Induces T Cell Unresponsiveness. Bank of   America ? Giannini Foundation; 7/95-7/96; $25,000 for salary support awarded to Nancy Krieger.
  • Cytokine Mechanisms of Tolerance in Liver Transplantation. American Gastroenterological Association Student Fellowship Award; 1995; $2,500 for salary support awarded to Daniel Most.
  • Cytokine Mediated Immune Dysregulation in Transplant Tolerance. American Academy of Allergy and Immunology Summer Fellowship; 1995; $1,500 for salary support awarded to Daniel Most.
  • The Role of Hepatocyte Growth Factor in Liver Transplantation.  OTL Research Initiative Grant, Stanford University. Edward J. Alfrey, Principle Investigator. 3/97-8/98, $24,938 (direct costs).

Grant Support (Projects Completed)

  • A Randomized, Comparative Trial of the Effects of Antilymphocyte Induction on Tacrolimus plus Mycophenolate Mofetil Maintenance Immunosuppression after Simultaneous Kidney/Pancreas Transplantation. Fujisawa USA; Edward J. Alfrey, Principal Investigator. 2/98-5/99, $37,750 (total costs).
  • Stanford Elderly Donor Evaluation. Willametta Day Foundation; Edward J. Alfrey, Principal Investigator; 2/98-5/00;  $58,650 (total costs).
  • A Double-Blind, Comparative Study of the Effect of Two Dose Levels of Sirolimus Versus Azathioprine, Administered Concomitantly with Standard  Immunosuppressive Therapy in Renal Allograft Recipients. Wyeth-Ayerst; Edward J. Alfrey, Co-Investigator; 8/96-1/00; $312,030.
  • A Randomized, Comparative Trial of Prograf (Tacrolimus, FK506) in Combination with Azathioprine or Mycophenolate (MMF) vs. Neoral (Cyclosporine) with Mycophenolate Mofetil after Cadaveric Renal Transplantation. Fujisawa USA; Edward J. Alfrey, Co-Investigator; 12/96-12/00; $108,250.
  • A Comparative Study of the Effect and Equivalence of Sirolimus Oral Liquid versus Sirolimus Tablets, Administered with Cyclosporine and Corticosteroids in Renal Allograft Recipients. Wyeth-Ayerst; Edward J. Alfrey, Co-Investigator; 1/98-12/99; $234,001.
  • A Pharmacokinetic and Safety, Open Label, Conversion study of Abbott Cyclosporine and Neoral in Stable Six-Month Post-Renal Allograft Recipients. Abbott Laboratories; Edward J. Alfrey, Co-Investigator; 3/98-3/99; $199,996.
  • Educational Grant. Fujisawa USA. Edward J. Alfrey, $6,100 (total costs).

Grant Support (Clinical) Active

  • Drug Study in De Novo Renal Allograft Recipients. Wyeth Ayerst Research Labs. 1/05-1/07. Edward J. Alfrey, P.I. $116,250 Total costs.
  • A Multicenter, Double-blind, Randomized, Parrallel Group Study on Tolerability and Safety of ERL080A vs. Mycophenolate Mofetil in Maintenance Renal Transplant Patients. Novartis. 8/00-present. Edward J. Alfrey, P.I. $96,595 Total costs.
  • A Case-Control Study of serious Post-Transplant Lymphoproliferative Disease in Renal Transplant Recipients. Imugenix Pharmaceutical. 11/00-present. Edward J. Alfrey, P.I. $28,600 Total costs.
  • A Double-Blind, Randomized Trial of Steroid Withdrawal in Sirolimus- and Cyclosporine-Treated Primary Transplant Recipients.? 1/26/01-present.? The National Institutes of Health,? National Institute of Allergy and Infectious Diseases, Division of Genetics and Transplantation.? William Harmon, M.D., P.I. Edward J Alfrey, site P.I. $70,000 Total costs.
  • Optimizing Prograf Therapy in Maintenance Allografts (OPTIMA). Fujisawa. 8/03 ? Present. Edward J. Alfrey, site P.I. $70,275 Total costs.

Students and Fellows Trained

  • Larisse K. Lee 1992-94 Resident in Surgery, Massachusetts General Hospital
  • Daniel Most 1993-94  Resident in Plastic Surgery, Johns Hopkins Hospital
  • Crystine M. Lee 1994-96 Attending Surgeon, General Surgery
  • Malaika M. Witter 1994-95     Attending Surgeon, Head and Neck Surgery
  • Nancy R. Keiger 1994-95   Assistant Professor, Mount Sinai School of Medicine
  • Gary Shen 1995-96  Associate Professor, Surgery, University of Nevada Las Vegas
  • Sean Cao  1996-97  Assistant Professor, University of California Irving
  • Amy J. Markezich 1996-97      Resident
  • Maria T. Millan  1997-99      Assistant Professor, Stanford University
  • Jonathan T. Carter 1998-99    Resident in Surgery, University of California San Francisco
  • Amy D. Lu 1998-00 Assistant Professor, Surgery, Georgetown University

Research Abstracts Presented - presenting author:

1.    Didemnin B Prolongs Skin Allograft Survival in Mice. Alfrey, EJ, Montgomery, D, Zukoski, CF. Society of University Surgeons, Residents Program, San Antonio, Texas, (2/19/88).

2.    Recent Increase in Monomorphous and Polymorphous Post Transplant Lymphoproliferative Disorder (PTLD).  Alfrey EJ, Friedman AL, Grossman RA, Perloff LJ, Naji A, Barker CF, Montone KT, Tomaszewski JE, Chmielewski C, Holland T, Zmijewski C, Dafoe DC.  American Society of Transplant Physicians, Chicago, Illinois, (5/29/91).

3.    Tolerance to Liver but not Heart Allografts after Intrathymic (IT) Inoculation of Donor Antigen. Alfrey, EJ, Wang, X, Holm, B, Dafoe, DC. (poster) American Society for the Study       of Liver Disease, Chicago, Illinois, (11/4/93).

4.    Haplotype Specificity of Intrathymic Tolerance. Alfrey, E, Wang, X, Lee, L, Holm, B, Adams, G, Dafoe, DC. (poster) Clinical Immunology Society, Los Angeles, CA. (4/23/94).

5.    Purified CD8+  T Cell Response In Vitro. Alfrey, EJ, Holm, B, Dafoe, DC.  (poster) Clinical Immunology Society, Los Angeles, CA. (4/23/94).

6.    The Use of Spiral Computed Tomography (CT) for Kidney Donor Evaluation in Living Related Transplantation (LRT).  Alfrey, EJ, Rubin, G, Kuo, PC, Waskerwitz, JA, Scandling, JD Mell, M, Jeffrey, RB, Dafoe, DC.  American Society of Transplant Physicians, Chicago, Illinois, (5/17/94).

7.    Comparison of Two Different Groups of Tolerant Liver Allografted Rats, Spontaneous vs Induced. Alfrey EJ, Wang X, Lee L, Holm B, Adams GA, Dafoe DC. Association for Academic Surgery, Albuquerque, New Mexico, (11/19/94).

8.    Interferon Gamma (IFN-?) and Interleukin-10 (IL-10) mRNA are Upregulated After Orthotopic Liver Transplantation (OLT) in Tolerant Rats. Most D, Wang X, Lee L, Holm B, Ro J, Sibley RK, Huie P, Dafoe DC, Alfrey EJ. Society of University Surgeons, Denver CO, (2/11/95).

9.    Both Th1 and Th2 Cytokine Profiles are Active in Tolerance. Alfrey EJ, Krieger NR, Holm B, Witter M, Huie P, Sibley R, Dafoe DC. (poster) Basic Sciences Symposium of the Transplantation Society, Noordwijkerhout, The Netherlands, (9/17/95).

10.   Predominance of IL-4 mRNA Expression Early After Experimental Liver Transplantation. Krieger NR, Yamaguchi A, Huie P, Sibley RK, Dafoe DC, Alfrey EJ. American Association for the Study of Liver Disease, Chicago, IL. (11/5/95).

11.   The Variability of Naive Rat Lymphocyte Proliferative Responses In Vitro. Alfrey EJ, Holm B. (poster) Southwestern Surgical Congress, Scottsdale, AZ. (4/28/96).

12.   Cytokine Kinetics and Localization after Experimental Liver Transplantation. Alfrey EJ, Krieger NR, Yamaguchi A, Holm B, Huie P, Sibley RK, Dafoe DC. (poster) American Society of Transplant Surgeons, Dallas TX., (5/30/96).

13.   Use of an Augmented Urinary Bladder can be Catastrophic in Renal Transplantation. Alfrey EJ, Conley S, Tanney D, Mak R, Scandling JD, Dafoe DC, Hammer G, Orlandi P, Page L, Salvatierra O. (poster) The International Congress of the Transplantation Society, Barcelona, Spain, 8/25/96.

14.   Cytokines and Bile Duct Proliferation after Orthotopic Liver Transplantation. Alfrey EJ, Krieger NR, Yamaguchi A, Holm B, Huie P, Sibley RK, Dafoe DC. (poster) Association for Academic Surgery, Chicago IL. (11/15/96).

15.   Th1 and Th2 Cytokines after Orthotopic Liver Transplantation (OLT). Alfrey EJ, Krieger NR, Huie P, Sibley RK, Dafoe DC. (poster) Tolerance Induction, Breckenridge, CO. (1/21/97).

16.   When Should Expanded Criteria Donors be used for Single Versus Dual Kidney Transplants? Lee CM, Scandling JD, Pavlakis M, Markezich AJ, Dafoe DC, Alfrey EJ. American Society of Transplant Physicians, Chicago IL. 5/13/97.

17.   Kidneys that Nobody Else Wanted. Lee CM, Scandling JD, Pavlakis M, Markezich AJ, Salvatierra O, Dafoe DC, Alfrey EJ. The Fourth International Society for Organ Sharing, Washington D.C. 7/11/97. 

18.   Expanded Criteria Donor Kidneys: Outcome in Dual versus Single Kidney Transplants.  Alfrey EJ, Lee CM, Scandling JD, Pavlakis M, Markezich AJ, Salvatierra O, Dafoe DC. The Fourth International Society for Organ Sharing, Washington D.C. 7/11/97.

19.   Matching Does not Improve Outcome from Aged Marginal Kidney Donors. Alfrey EJ, Lu AD, Carter JT, Dafoe DC. The International Congress of the Transplantation Society, Rome, Italy, 8/25/00. 

Research Abstracts Presented - contributing author:

1.Tolerance to Subsequent Donor Strain Heart Allografts After Intrathymic Inoculation of Donor Antigen is Haplotype Restricted in the Rat. Alfrey, EJ, Wang, X, Lee, L, Holm, B, Kim, J, Adams, G, Dafoe, DC.  Fifth International Alexis Carrel Conference, Munich, Germany, poster (6/22/94).

2. Increased Tissue Nitric Oxide Synthase (NOS) mRNA After Spontaneous Tolerance (ST) Following Orthotopic Liver Transplantation (OLT). Most D, Kuo PC, Lee L, Huie P, Sibley RK, Alfrey EJ. Society of University Surgeons, Residents Program, Denver CO, (2/11/95).

3.Anti-CD2 Monoclonal Antibody Induces T Cell Unresponsiveness in Vascularized Rat Cardiac Allografts. Krieger NR, Holm B, Bromberg JS, Dafoe DC, Alfrey EJ. Society of University Surgeons, Residents Program, Denver CO, (2/11/95).

4.ATG Versus OKT3 for Induction Immunotherapy after Kidney/Pancreas Transplantation. Krieger NR, Kuo PC, Busse-Henry S, Scandling JD, Dafoe DC, Alfrey EJ. (poster) Southwest Surgical Congress, San Antonio, Texas (4/23/95).

5.Anti-CD2 Monoclonal Antibody Induced Tolerance: Evidence for Upregulation of Both TH1 and TH2 Type Cytokine Profiles. Krieger NR, Holm B, Most D, Huie P, Sibley RK, Bromberg JS, Dafoe DC, Alfrey EJ. American Society of Transplant Surgeons, Chicago, IL. (5/18/95).

6.The Effect of Hepatic Arterialization in Experimental Liver Transplantation in Rats. Yamaguchi A, Krieger NR, Holm B, Dafoe DC, Alfrey EJ. Congress of the Asian Society of Transplantation, Seoul South Korea, (8/95).

7. Cardiac Allograft Unresponsiveness Using a Posttransplant Strategy. Krieger NR, Quezada VR, Huie P, Holm B, Sibley RK, Dafoe DC, Alfrey EJ. Association for Academic Surgery, Dearborn MI. (11/10/95).

8.Low Dose OKT3 Treatment for Induction/Rejection in Multi-organ Transplantation. Diekman-Guiroy B, Scandling JD, Busse-Henry S, Kuo PC, Dafoe DC, Alfrey EJ. (poster) American Society of Nephrology, San Diego CA., (11/6/95).

9.Similar Outcomes in Diabetic Patients after Simultaneous Kidney/Pancreas Versus Kidney Alone Transplantation. Lee CM, Razo P, Krieger NR, Dafoe DC, Scandling JD, Alfrey EJ. (poster) Southwestern Surgical Congress, Scottsdale, AZ. (4/28/96).

10. The Kidneys that Nobody Wanted. Lee CM, Scandling JD, Shen GK, Knoppel CL, Dafoe DC, Alfrey EJ. American Society of Transplant Physicians, Dallas TX. (5/29/96).

11.Outcome in Diabetic Patients after Simultaneous Pancreas-Kidney Versus Kidney Alone Transplantation. Lee CM, Krieger N, Dafoe DC, Alfrey EJ. (poster) Association for Academic Surgery, Chicago IL. (11/15/96).

12.The Return of the Kidneys that Nobody Wanted. Lee CM, Scandling JD, Pavlakis M, Markezich AJ, Dafoe DC, Alfrey EJ. American Society of Transplant Physicians, Chicago IL. 5/13/97.

13.FK506 and Mycophenolate Mofetil: The Superior Strategy for Simultaneous Pancreas-Kidney Patients. Lee CM, Scandling JD, Pavlakis M, Markezich AJ, Dafoe DC, Alfrey EJ. (poster) American Society of Transplant Surgeons, Chicago IL. 5/15/97.

14.Mismatch is Associated with Early Function in Cadaveric Renal Transplantation. Witter MM, Lee CM, Markezich AJ, Dafoe DC, Ting A, Grumet FC, Alfrey EJ. The Asociation for Academic Surgery, Dallas TX. 11/7/97. 

15.Cyclosporine A and Mycophenolate Mofetil is the Superior Treatment Strategy in Cadaveric Renal Transplantation. Lee CM, Markezich AJ, Dafoe DC, Alfrey EJ. The Association for Academic Surgery, Dallas TX. 11/7/97.

16.Are Two Kidneys Better Than One: Outcome in Single vs En Bloc and Dual Kidney Transplants. Lee CM, Prapong P, Carter JT, Scandling JD, Pavlakis M, Dafoe DC, Alfrey EJ. The American Society of Transplant Physicians, Chicago IL. 5/11/98.

17.Disparate Early Function in Matched Kidneys is not due to Racial or Panel Reactive Antibody Differences. Lee CM, Matta J, Scandling JD, Pavlakis M, Dafoe DC, Alfrey EJ. (poster) American Society of Transplant Surgeons, Chicago IL. 5/13/98.

18. Severe Glomerular Sclerosis is not Associated with an Increase in Graft Loss after Cadaveric Renal Transplantation. Alfrey EJ, Desai D, Lee CM, Millan M, Prapong W, Scandling JD, Pavlakis M, Dafoe DC. (poster) Third International Congress on Pediatric Transplantation, Boston, MA. 7/9/98.

19. Are Two Kidneys Better Than One: Outcome in Single vs Pediatric En Bloc and Dual Kidney Transplants. Lee CM, Prapong P, Carter JT, Scandling JD, Pavlakis M, Dafoe DC, Alfrey EJ. (poster) Third International Congress on Pediatric Transplantation, Boston, MA. 7/10/98.

20. Dual Kidney Transplants: Older Donors for Older Recipients. Lee CM, Carter JT, Weinstein R, Pease H, Scandling JD, Pavlakis M, Dafoe DC, Alfrey EJ. Clinical Papers, American College of Surgeons, 10/27/98, Orlando, FL.

21. Excellent Outcome in Dual Kidney Transplants from Aged Expanded Criteria Donors. Lu AD, Lee CM, Pease H, Weinstein B,  Carter J. T., Prapong W,  Scandling J.D., Pavlakis M, Salvatierra O, Millan M, Dafoe DC, Alfrey EJ. Pacific Coast Surgical Society, 2/15/99, Cabo San Lucas, Mexico.

22.Utilization of Kidneys from Older Cadaveric Donors: Older Recipients Should Receive Older Donor Kidneys. Lee CM, Prapong W, Scandling JD, Pavpakis M, Dafoe DC, Alfrey EJ. (poster) American Society of Transplantation,  Chicago IL. 5/16/99.

23.Outcome in Older Patients with Delayed Graft Function (DGF) after Cadaveric Renal Transplantation (CRT): Greater Age does not Decrease Graft Survival in Pateints with DGF. Lee CM, Prapong W, Scandling JD, Pavpakis M, Dafoe DC, Alfrey EJ. (poster) American Society of Transplantation,  Chicago IL. 5/16/99.

24.Estimated Donor Creatinine Clearance Predicts Graft Survival and Initial Function in Recipients of Older Cadaveric Renal Transplants. Carter JT, Lee CM, Lu AD, Weinstein RJ, Pease HM, Currie CE,  Dafoe DC, Alfrey EJ. American Society of Transplantation,  Plenary session, Chicago IL. 5/18/99.

25.Evaluation of the Older Cadaveric Kidney Donor: The Impact of Donor Hypertension on Graft Performance and Survival. Carter JT, Lee CM, Weinstein RJ, Lu AD, Dafoe DC, Alfrey  EJ. American Society of Transplant Surgeons, 5/19/99, Chicago IL.

26. Outcome in Recipients of Dual Kidney Transplants: Analysis of the First 100 Registry Patients. Lu AD, Carter JT, Kuo PC, Johnson LB, Taylor R, Stratta R, Chavin K, Ratner L, Bowers VD, Alfrey EJ. American Society of Transplant Surgeons, 5/20/99, Chicago IL.

27. The Effect of Age and Prolonged Cold Ischemia Times on the National Allocation of Cadaveric Renal Allografts. Lee CM, Carter JT, Randall HB, Hirose R, Stock PG, Melzer JS, Dafoe DC, Freise CE, Alfrey EJ. Association for Academic Surgery, 11/19/99, Philadelphia, PA

28. Severe Glomerular Sclerosis is not Associated with Poor Outcome after Kidney Transplantation. Lu AD, Dev Desai,Myers BD, Dafoe DC, Alfrey EJ. Southwestern Surgical Association, 4/11/00, Colorado Springs, CO.

29. Excellent Outcome from Cadaveric Kidneys Despite Glomerular Sclerosis and Vasculopathy. Lu A.D., Desai D. Layafette R.A., Myers B.D., Scandling J.D. Dafoe D.C., Alfrey E.J. AST/ASTS Transplant 2000, Chicago IL. 5/00.

30. Excellent Outcome Despite Adverse Histology After Cadaveric Kidney Transplantation. Lu AD, Dev Desai, Myers BD, Dafoe DC, Alfrey EJ.  The International Congress of the Transplantation Society, Rome, Italy, 8/25/00.

31. The Consequences of Delayed Graft Function after Kidney Transplantation. Boissy AR, Lerner SM, Tan JC, Shaw V, Javid B, Scandling JD, Dafoe DC, Alfrey EJ. The Association for Academic Surgery, Boston, MA. 11/7/02.

32. No Increase in Rejection or Graft Loss in Kidney Transplant Recipients with Thrombophilias Treated with Anticoagulation and Triple Immunosuppression. Pagano CR, Dawson L, Dick A, Lerner SM, Valenia T, Braun J, Smith M, Farrell C, Alfrey EJ. The Third International Congress on Immunosuppression. (Poster) San Diego, CA. 12/9/04.

33. Has the Expedited Placement of Expanded Criteria Donor Kidneys been Successful? A Single Center Experience. Lerner SM, Dick AA, Pagano CR, Braun JL, Johnston BM, Grubor AE, Romberger L, Alfrey EJ. (Poster of Distinction) The American Transplant Congress 2005, Seattle, WA. 5/22/04.

34. Does Anticoagulation Abrogate the Immunological Consequences of Thrombophilia after Kidney Transplantation? Pagano CR, Dawson L, Dick AA, Lerner SM, Valenia TM, Braun JL, Farrell C, Smith MA, Alfrey EJ. (Poster) The American Transplant Congress 2005, Seattle, WA. 5/22/04.

Research Abstracts Presented - contributing author:

1. A Local Experience With Nationally Shared Phenotypically Identical Kidneys.  Friedman A, Alfrey E, Nathan H, Abrams J, Gifford R, Morris M, West J, Samimi F, Dunn S, Barker C, Grossman R, Dafoe D.  The American Society of Transplant Physicians, (poster) Chicago, Illinois, (5/29/91)

2. Insulin-Like Growth Factor-1 (IGF-1) Results in Successful Fetal Pancreas (FP) Transplantation in the Intramuscular (IM) Site.  Wang X, Lee L, Adams GA, Alfrey EJ, Dafoe DC.  American College of Surgeons, Surgical Forum; San Francisco, California, (10/13/93).

3. Regulation Of Na+ Transport By The Postischemic Human Kidney.  D Alejandro, J Nelson, R Sibley, D Dafoe, E Alfrey, J Scandling, B Myers.  The American Society of Nephrology, Boston, Massachusetts, (11/14/93).

4. The Role of Magnetic Resonance Imaging in Evaluation of Potential Liver Transplant Candidates. Mell M, Alfrey E, McDonnell C, Jeffrey B, Garcia G, Dafoe D.  The American Society of Transplant Physicians, (poster), Houston, Texas, (5/93).

5. Pre-Operative Assessment of Living Renal Donors: Spiral CT as an Alternative to Conventional Angiography and Intravenous Urography.  Rubin GD, Jeffrey RB, Alfrey EJ, Dake MD, Semba CP, Napel S.  The Society of Computed Body Tomography and Magnetic Resonance, Seattle, Washington, (4/17/94).

6. Insulin-Like Growth Factor-1 (IGF-1) Enhances Reversal of Diabetes By Fetal Pancreas Isografts (FP).  Adams GA, Wang X, Lee l, Alfrey EJ, Dafoe DC.  Central Surgical Association, Chicago, Illinois, (3/4/94).

7. Functional Correlates of Hepatic Hemodynamics in Liver Transplant Candidates: Noninvasive Determination by Magnetic Resonance Imaging (MRI).  Paul Kuo, Edward J. Alfrey, R. Brooke Jeffrey, Gabriel Garcia, Donald C. Dafoe.  American Society of Transplant Physicians, Chicago, Illinois, (5/17/94).

8. Regulation of Na+ Transport by the Postischemic Human Transplant Kidney.  Dina Alejandro, Phil Huie, James Nelson, Richard Sibley, Donald C. Dafoe, Edward J. Alfrey, Paul C Kuo, John Scandling, Bryan Myers. American Society of Transplant Physicians, Chicago, Illinois, (5/18/94).

9. Effects of Insulin - Like Growth Factor-1 (IGF-1) on Fetal Pancreas (FP) isografts on Fetal Pancreas (FP) Isografts in Diabetic Rats.  Gregg A. Adams, Xuegong Wang, Larisse Lee, Christopher Piercy, Edward J. Alfrey, Donald C. Dafoe.  American Society of Transplant Surgeons, Chicago, Illinois, (5/19/94).

10. Liver Transplant Candidates Exhibit Volume-Mediated Pulmonary Hypertension. Kuo PC, Vagelos RH, Alfrey EJ, Garcia G, Dafoe DC. American Society for the Study of Liver Disease, Chicago, Illinois, (11/11/94).

11. A Magnetic Resonance Imaging-Derived Parameter of Portal Flow Predicts Pulmonary Hypertension in Liver Transplant Candidates. Kuo PC, Alfrey EJ, Li K, Vagelos R, Valentine H, Garcia G, Dafoe DC. Central Surgical Association, Cleveland, Ohio, (3/10/95).

12. Orthotopic Liver Transplantation with Selective use of Venovenous Bypass. Kuo PC, Alfrey EJ, Garcia G, Haddow G, Dafoe DC. Southwest Surgical Congress, San Antonio, Texas (4/23/94).

13. DES-(1-3)-IGF-1 Accelerates Recovery and Reduces Catabolism after Renal Transplantation in the Rat. Maestri M, Adams GA, Holm B, Alfrey EJ, Rabkin R, Dafoe DC. American Society of Transplant Surgeons, Chicago, IL. (5/19/95).

15. Differential Cellular Localization of Inducible Nitric Oxide Synthase mRNA in Acute Rejection of Vascularized Allografts. Paul C. Kuo, Edward J. Alfrey , Nancy R. Krieger, Richard K. Sibley. Joint Congress on Liver  Transplantation, London, England; awarded the ILTS/LICAGE Joint Congress Fellows Prize (9/27/95).

16.Inhibition of Hepatocyte Nitric Oxide Production Increases Graft Injury in a Tolerant Model of Rat Liver Transplantation. Paul C. Kuo, Edward J. Alfrey, Keith Abe, Richard K. Sibley.  Joint Congress on Liver  Transplantation, London, England (9/27/95).

17. Differential Cellular Localization of Inducible Nitric Oxide Synthase mRNA in Acute Rejection of Vascularized Allografts. Kuo PC, Alfrey EJ, Krieger NR, Huie P, Sibley RK, Dafoe DC. Surgical Forum, American College of Surgeons, New Orleans, LA. (10/23/95).

18. Successful Functional Outcome of a Human Syngeneic Bowel Transplant. D Johnson, J Rimmer, J Morris, R Dalman, K Li, P Kuo, E Alfrey, JA Bastidas, D Dafoe, H Oberhelman.       Papers of the Clinical Congress, American College of Surgeons, New Orleans, LA. (10/26/95).

19.Systemic Inflammatory Response Syndrome after Human Syngeneic Intestinal Transplantation: Evidence for Disruption of Enterocyte Barrier Function. Kuo PC, Marks WH, Lieberman J, Johnson D, Alfrey EJ, Dafoe DC. Fourth International Symposium on Small Bowel Transplantation, Pittsburgh PA. (10/16/95).

20. Vasodilator Unresponsiveness of Acute Postischemic Renal Allograft Failure. Tse E, Vinot O, Huie P, Sibley RK, Wang BY, Cooke JP, Dafoe D, Alfrey E, Scandling J, Myers BD. American Society of Nephrology, San Diego, CA. (11/5/95).

21. Utilization of the Older Donor for Renal Transplantation. Kuo PC, Johnson LB, Alfrey EJ, Schweitzer EJ, Dafoe DC, Waskerwitz J, Bartlett ST. Southwestern Surgical Congress, Scottsdale, AZ. (4/30/96).

22. High Incidence of Discontinuation or Reduction in Dosage of Mycophenolate Mofetil in Kidney and Kidney/Pancreas Transplantation. Scandling JD, Alfrey EJ, Tibble S, Salvatierra P, Mell D, Salvatierra O, Dafoe DC. (poster) American Society of Transplant Physicians, Dallas TX., (5/29/96).

23. Eradication of CMV Reactivation Disease: Prophylaxis Using High Dose Acyclovir and Preemptive Ganciclovir in Kidney and Kidney/Pancreas Transplantation. Shen GK, Alfrey EJ, Knoppel C, Dafoe DC, Scandling JD. (poster) American Society of Transplant Physicians, Dallas TX., (5/29/96).

24. Augmenter of Liver Regeneration Enhances Reversal of Diabetes by Fetal Pancreas Isografts. Adams GA, Maestri M, Squires EC, Alfrey EJ, Starzl TE, Dafoe DC. American Society of Transplant Surgeons, Dallas TX., (5/30/96).     

25. Dual Adult Renal Allografts- A technique for Expansion of the Cadaveric Renal Donor Pool. Johnson L, Kuo P, Dafoe DC, Schweitzer E, Alfrey EJ, Salvatierra P, Bartlett S. (poster) The International Congress of the Transplantation Society, Barcelona, Spain, 8/25/96.

26. Mycophenolate Mofetil in Children with Renal Transplants- Use as a Primary Immunosuppressant and as Rescue for Chronic Rejection., Conley S, Tanney D, Mak R, Kim P, Alfrey EJ, Salvatierra O. (poster) The International Congress of the Transplantation Society, Barcelona, Spain, 8/25/96.

27.  Primary CMV Disease Prophylaxis: No Benefit from the Addition of CMV Immune Globulin to High Dose Acyclovir and Targeted Gancyclovir in Kidney and Kidney/Pancreas Transplantation. Corrigan G, Alfrey EJ, Pavlakis M, Knoppel C, Dafoe DC. (poster) American Society of Transplant Physicians, Chicago IL. 5/11/97.

28. The Pathophysiology of Acute Human Renal Allograft Rejection. Jani Alkesh, Corrigan G, Kwon O, Scandling JD, Alfrey EJ, Dafoe DC, Derby G, Myers BD, Pavlakis M. (poster) American Society of Transplant Physicians,  Chicago IL. 5/10/98.

29. Combined Trophic Factors Promote Success of Fetal Pancreas Grafts. Desai DM, Adams GA, Wang X, Alfrey EJ, Dafoe DC. American Society of Transplant Surgeons, Chicago IL. 5/14/98.

30. A Two Dose Regimen of Daclizumab (Zenapax) in High-Risk Renal Transplant Recipients. Millan M, Pavlakis M, Alfrey E, Salvatierra O, Dafoe D, Scandling J.  (poster) American Society of Transplantation, Chicago IL. 5/16/99.

31. Prolonged Cold Ischemia Time Obviates the Benefits of 0 HLA Mismatches in Renal Transplantation. Lee CM, Carter JT, Alfrey EJ, Ascher NL, Roberts JP, Freise CE. Pacific Coast Surgical Association (Resident Research Prize), San Francisco, CA. 2/20/00.

32. The Determinants of GFR During Acute Human Renal Allograft Rejection. Jani A., Polhemus K., Corrigan G., Osun K., Alfrey E., Scandling J., Myers B., Pavlakis M. AST/ASTS Transplant 2000, Chicago IL. 5/00.

33. The Role of Antibody Induction in Simultaneous Pancreas Kidney (SPK) Transplant Patients Receiving Tacrolimus + Mycophenolate Moffetil (MMF) Immunosuppression. Kaufman D., Burke G., Bruce D., Sutherland D., Johnson C., Gaber A., Merion R., Schweitzer E., Marsh C., Alfrey E., Leone J., Concepion W., Stegall M., Stock P., Danovich D., Tolzman D., Scotellaro P., Salm K., Keller A., Fitzsimmons W. AST/ASTS Transplant 2000, Chicago IL. 5/00.

34. The Effect of Surgical Site Infection on Outcomes and Resource Utilization After Liver Transplantation. Hollenbeak C.S., Alfrey EJ, Souba WW. The Society of University Surgeons, Chicago IL. 2/01.

35. Tacrolimus and Mycophenloate Mofetil +/- Antibody Induction in Simultaneous Pancreas Kidney Transplantation: One Year Results. Burke GW, Kaufman DB, Bruce DS, Sutherland D, Johnson CP, Gaber AO, Merion RM, Schweitzer E, Marsh CL, Gruber SA, Alfrey EJ, Leone JP, Conception W, Stegall MD, Gores PS, Danovich G, Nunnally PJ,  Henning AK, Fitzsimmons WE. The Second International Congress on Immunosuppression, San Diego CA. 12/01.

36. The Effect of Antibody Induction in Simultaneous Pancreas Kidney Transplant Patients Receiving Tacrolimus and Mycophenolate Mofetil: Two Tear Results. Burke GW, Kaufman DB, Bruce DS, Sutherland D, Johnson CP, Gaber AO, Merion RM, Schweitzer E, Marsh CL, Gruber SA, Alfrey EJ, Leone JP, Conception W, Stegall MD, Gores PS, Danovictch G, Kuehnel FR, Henning AK. American Transplant Congress, Washington DC, 5/02.

37. Dual Kidney Transplantation: Five-Year Outcome in a Single Center. Tan JC, Millan MT, Dafoe DC, Alfrey EJ, Scandling JD. American Transplant Congress, Washington DC, 5/02.

38. Prevalence of Hypercoagulable Disorders in Potential Kidney Transplant Recipients. Zuberi A, Alfrey EJ, Lerner SM, Nifong TP, Javid B. The American Society of Nephrology, Philadelphia, PA. 11/02.

39. Prevalence of Anemia in Kidney Transplant Recipients. Javid B, Lerner SM, Goldfarb-Rumyanzev AS, Alfrey EJ. (poster) The American Society of Nephrology, Philadelphia, PA. 11/02.

40. Randomized Trail of Prograf+ MMF or Azathioprin Versus Neoral+MMF after Cadaveric Kidney Transplantation: Results at Three Years. Johnson C, Gonwa T, Light J, Hardy M, Ahsan N, Metzger R, Danovich G, Corwin C, Halloran P, Wachs M, Alfrey E, Rocher L, Stegall M, Shields C, Mulloy L, Soeresen J, Scandling J.  The American Society of Nephrology, Philadelphia, PA. 11/02.

41. Validation of a Screening Protocol for Coronary Artery Disease in Kidney and/or Pancreas Transplant Candidates with Type I Diabetes Mellitus. Ma IWY, Valantine HA, Atsuko S, Waskerwitz J, Dafoe D, Alfrey E, Tan J, Millan M, Busque S, Scandling JD. (poster) The American Society of Nephrology, Philadelphia, PA. 11/02.

42. Current Prevalence of Coronary Artery Disease in Kidney Transplant Candidates with Type I Diabetes Mellius. Ma IWY, Valantine HA, Atsuko S, Waskerwitz J, Dafoe D, Alfrey E, Tan J, Millan M, Busque S, Scandling JD. (poster) The American Society of Nephrology, Philadelphia, PA. 11/02.

43. Detection of Coronary Artery Disease in Kidney and/or Pancreas Transplant Candidates with Type I Diabetes Mellitus. Ma IWY, Valantine HA, Atsuko S, Waskerwitz J, Dafoe D, Alfrey E, Tan J, Millan M, Busque S, Scandling JD. (poster) The American Society of Nephrology, Philadelphia, PA. 11/02.

Presentations- invited speaker:

  • New Advances in Parathyroid Localization.  Twenty-Fourth Annual Medical and Surgical Seminar, Coconino Medical Society, Flagstaff, Arizona, (7/29/88).
  • Parathyroid Localization.  Tucson Surgical Society, Tucson, Arizona, (9/30/88).
  • Animal Models in Transplantation Research. Harlan Continuing Education Conference, Stanford, CA., (9/19/94).
  • Posttransplant Lymphomas. National Kidney Foundation of Northern California, 27th Annual Medical Symposium, Foster City, CA., (9/23/94).
  • Dilemmas in transplantation: Who should be transplanted and how should organs be distributed. Distinguished Career Lecture, University of Denver, Denver CO. (10/23/95).
  • Expanded Criteria Donors for Kidney Transplantation. UNOS Region 5 meeting, Las Vegas, NV. (10/18/96).
  • Dual Kidney Transplants. UNOS Region 5/6 Transplant Coordinators meeting, San Francisco, CA. (2/19/97).
  • The Use of Expanded Criteria Donors for Single and Dual Renal Transplants. Oregon Health Sciences University Transplant Conference, Portland, OR. (4/10/97).
  • Expanded Criteria Donors and Dual Kidney Transplants. California Pacific Medical Center Transplant Conference, San Francisco, CA. (8/6/99).
  • Dual Kidney Transplants. Transplant Speakers Forum, Brooklyn, N.Y. 9/30/99.
  • Expanded Criteria Donor Kidneys. National Kidney Foundation of Northern California, 32nd Annual Medical Symposium, Foster City, CA. 9/24,99.
  • Dual Transplants/Marginal Donors. Posttransplant Immunosuppression: New Paradigms, University of Minnesota, Minneapolis, MN. 10/20/99.
  • Tailoring the Use of Expanded Criteria Donors to the Recipient. Transplant Conference, The University of California Davis, Sacramento, CA. 3/8/00
  • Expanded Criteria Donors. St. Francis Hospital Nephrology Conference, Waikiki, HI. 5/4/00.
  • Dual Renal Transplantation. St. Francis Hospital Surgical Grand Rounds, Waikiki, HI. 5/5/00.
  • Pushing the Limits: The Dual Kidney Transplant Registry. The International Congress of the Transplantation Society, Rome, Italy, 8/21/00.
  • The True Benefit of HLA Matching. AST/ASTS Joint meeting. 5/12/01, Chicago IL.
  • Marginal Donors. AST/ASTS Joint meeting. 5/14/01, Chicago IL.
  • Discussant, Surgical Forum, ACS Clinical Congress, 10/11/01, New Orleans, LA.
  • Panel Discussant, Why We Use the Organs We Use. American Society of Transplant Surgeons Winter Symposium, Miami, FL. 1/27/02.
  • Invited participant, National Consensus Conference on the Kidney Transplantation Wait List, Philadelphia, PA. 3/4/02-3/5/02.
  • Marginal Donors. Luncheon workshop. American Transplant Congress, Washington DC, 5/02.
  • Single Donor Double Kidney Transplantation: Long-Term Results. The International Congress of the Transplantation Society, Miami FL. 8/27/02.
  • Dual Kidney Transplantation. Update on End-Stage Renal Disease. Hershey PA. 4/22/03.
  • Update on Immunosuppression. ASHI Northeastern Regional Workshop. Atlantic City, NJ. 5/2/03.

Bibliography:

1. Pons P, Holland B, Alfrey E, Markovchik V, Rosen P, Dinerman N.  An Advanced Emergency Care System at National Football League Games  Ann. Emerg. Med.; 9; 203-206; 1980.

2. Winkler J, Rosen P, Alfrey E.  Prehospital Use of the Glascow Coma Scale in Severe Head Injury.  J. Emerg. Med.; 2; 1-6; 1984.

3. Dunnington G, Alfrey E, Sampliner R, Kogan F, Putnam C.  Natural History of Cholelithiasis in Patients with Alcoholic Cirrhosis.  Ann. Surg.; 205; 226-9; 1987.

4. Alfrey E, Stanton C, Dunnington G, Malone J, Bernhard V.  Graft Appendiceal Fistulas.  J. Vasc. Surg.; 7; 814-7; 1988.

5. Alfrey E, Dafoe D, Perloff L, Naji A, Barker C.  Use of the Vascular Stapling Device in Pancreas Allograft Procurement.  Surg, Gyn and Obstet.; 171; 77-78; 1990.

6. Bromberg JS, Alfrey EJ, Barker CF, Chavin KO, Dafoe DC, Holland T, Naji A, Perloff LJ, Zellers LA, Grossman RA.  Adrenal Suppression and Steroid Supplementation in Renal Transplant Recipients.  Transplantation; 51; 385-390; 1991.

7. Dafoe DC, Bromberg JS, Grossman RA, Tomaszewski JE, Zmijewski CM, Perloff LJ, Naji A, Asplund MW, Alfrey EJ, Sack M, Zellers LA, Kearns J, Barker CF.  Renal Transplantation Despite a Positive Anti-Globulin Crossmatch with and without Prophylactic OKT3.  Transplantation; 51; 762-768; 1991.

8. Alfrey EJ, Perloff LJ, Asplund MW, Dafoe DC, Grossman RA, Bromberg JS, Holland T, Naji A, Barker CF.  Normocalcemia Thirteen Years After Successful Parathyroid Allografting in a Renal Transplant Recipient.  Surgery; 111; 234-236; 1992.

9. Alfrey E, Zukoski C, Montgomery D.  Prolongation of Skin Allograft Survival in Mice by Didemnin B.  Transplantation; 54; 188-189; 1992.

10. Alfrey EJ, Friedman AL, Grossman RA, Perloff LJ, Naji A, Barker CF, Montone KT, Tomaszewski JE, Chmielewski C, Holland T, Zmijewski C, Dafoe DC.  Two Distinct Patterns of Post-Transplantation Lymphoproliferative Disorder (PTLD): Early and late onset.  Clin. Transplantation; 6; 696; 1992.

11. Alfrey EJ, Friedman AL, Grossman RA, Perloff LJ, Naji A, Barker CF, Montone KT, Tomaszewski JE, Chmielewski C, Holland T, Zmijewski C, Dafoe DC. A Recent Decrease in the Time to Development of Monomorphous and Polymorphous Posttransplant Lymphoproliferative Disorder.  Transplantation;  54; 250-253; 1992.

12. Campos C, Alfrey EJ, Posselt AM, Odorico JS, Naji A, Barker CF, Intrathymic Inoculation of Donor Cell Promotes Survival of Rat Orthotopic Liver Allografts.Transplant Proc.; 25; 488-490; 1993.

13. Alfrey EJ, Smythe R, Friedman A, Meranze S, Grossman RA, Perloff LJ, Naji A, Barker CF, Dafoe DC.  Two Masqueraders of Transplant Renal Artery Stenosis (TRAS). Clinical Transplantation ; 7; 183-187; 1993.

14. Campos L, Alfrey EJ, Posselt AM, Odorico JM, Baker CF, Naji A.  Prolonged Survival of Rat Orthotopic Liver Transplants following Intrathymic Inoculation of Donor Strain Cells.  Transplantation ; 55; 866-870; 1993.

15. Friedman A L, Alfrey EJ, O?Connor TP, Hoffman MA, Dafoe DC, Lau HT.  Use of a Vascular Stapler to Revise the Retrohepatic Vena Cava of Reduced Size Orthotopic Liver Grafts.  J Am Coll Surg 1994; 178: 181-182.

16. Mell MW, Alfrey EJ, Rubin GD, Scandling JD, Jeffrey RB, Dafoe DC. Use of Spiral Computed Tomography in the Diagnosis of Transplant Renal Artery Stenosis. Transplantation 1994; 57: 746-748.

17. Kuo PC, Alfrey EJ, Scandling JD, Dake M, Dafoe DC.  Endovascular Stenting of the Abdominal Aorta Following Renal Transplantation.  Transplantation 1994; 57: 522-524.

18. Adams GA, Wang X, Lee KL, Piercy CE, Alfrey EJ, Dafoe DC.  Insulin-like Growth Factor-I Promotes Successful Fetal Pancreas Transplantation in the Intramuscular Site. Surgery 1994; 116: 751.

19. Adams GA, Wang X, Lee L, Alfrey EJ, Dafoe DC. Blockade of the Insulin-like Growth Factor-1 Receptor Affects Intramuscular Fetal Pancreas/Fetal Liver Isografts in Diabetic Rats.Trans Proc 1994; 26: 3331-3332.

20. Alfrey EJ, Rubin GD, Kuo PC, Waskerwitz JA, Scandling JD, Mell MW, Jeffrey RB, Dafoe DC. The Use of Spiral Computed Tomography in the Evaluation of Living Donors for Kidney Transplantation. Transplantation  1995; 59: 643-645.

21. Kuo PC, Dafoe DC, Alfrey EJ, Sibley RK, Scandling JD.  Posttransplant Lymphoproliferative Disorders and Epstein-Barr Virus Prophylaxis.  Transplantation 1995; 59:135-138.

22. Alejandro V, Scandling JD, Sibley RK, Dafoe DC, Alfrey EJ, Deen W, Myers BD. Mechanisms of Filtration Failure During Postischemic Injury of the Human Kidney: A Study of the Reperfused Renal Allograft. J Clin Invest 1995; 95: 820-831.

23. Alfrey EJ, Wang X, Lee, L, Holm B, Kim JY, Adams GA, Dafoe DC. Tolerance Induced by Direct Inoculation of Donor Antigen into the Thymus in Low and High Responder Rodents. Transplantation 1995; 59: 1171-1178.

24. Kuo PC, Li K, Alfrey EJ, Jeffrey RB, Garcia G, Dafoe DC.  Magnetic Resonance Imaging and Hepatic Hemodynamics:  Correlation With Metabolic Function in Liver Transplant Candidates.  Surgery 1995; 117: 373-379.

25. Rubin GD, Alfrey EJ, Dake MD, Semba CP, Sommer FG, Kuo PC, Dafoe DC, Jeffrey RB. Preoperative Assessment of Potential Living Renal Donors with Spiral CT. Radiology 1995; 195:457-462.

26. Kuo PC, Luikart H, Busse-Henry S, Hunt SA, Valentine HA, Stinson EB, Oyer PE, Scandling JD, Alfrey EJ, Dafoe DC.  Clinical Outcome of Cadaveric Renal Transplantation in Cardiac Allograft Recipients.  Clinical Transplantation 1995; 9: 92-97.

27. Alfrey EJ, Wang X, Lee L, Holm B, Adams GA, Dafoe DC. A Comparison of Spontaneous Versus Induced Tolerance in an Experimental Model of Rat Hepatic Allograft Transplantation. J Surg Res 1995; 58: 611-617.

28. Wang X, Alfrey EJ, Posselt A, Tafra L, Alak AM, Dafoe DC. Intraportal delivery of immunosuppression to intrahepatic islet allograft recipients. Trans International  1995; 8: 268-272.

29. Alfrey EJ, Most D, Wang X, Lee LK, Holm B, Krieger NR, Sibley RK, Huie P, Dafoe DC. Interferon Gamma (IFN?) and Interleukin 10 (IL-10) mRNA are Upregulated after Orthotopic Liver Transplantation in Rats: Evidence for Cytokine Mediated Immune Dysregulation. Surgery 1995; 118: 399-405.

30. Vinot O, Bialek J, Canaan-Kuhl S, Scandling JD, Dafoe DC, Alfrey EJ, Myers BD. Endogenous ANP in Postischemic Acute Renal Allograft Failure. Am Journ Physiol 1995; 296: 125-33.

31. Kuo PC, Alfrey EJ, Li K, Vagelos R, Valentine H, Garcia G, Dafoe DC. A Magnetic Resonance Imaging-Derived Parameter of Portal Flow Predicts Volume-Mediated Pulmonary Hypertension in Liver Transplant Candidates. Surgery 1995; 118: 685-691.

32. Kuo PC, Alfrey EJ, Garcia G, Haddow G, Dafoe DC. Orthotopic Liver Transplantation with Selective Use of Venovenous Bypass Am J Surg  1995; 170: 671-675.

33. Kuo PC, Krieger NR, Alfrey EJ, Scandling J, Dafoe DC. The Utility of Retroperitoneal Kidney Placement in Simultaneous Kidney Pancreas Transplantation. Clin Trans 1995; 6: 457-62.

34. Yamaguchi A, Krieger NR, Holm B, Dafoe DC, Alfrey EJ. Effect of Hepatic Arterialization (HA) in Experimental Liver Transplantation in Rats. Transplan Proc. 1996; 28: 1786-1787.

35. Kuo PC, Alfrey EJ, Abe KY, Huie P, Sibley RK, Dafoe DC. Cellular Localization and Effect of Nitric Oxide Synthesis in a Rat Model of Orthotopic Liver Transplantation  Transplantation  1996; 61: 305-312.

36. Krieger NR, Quezada VR, Huie P, Sibley RK, Dafoe DC, Alfrey EJ. Inoculation of Donor Antigen in a Posttransplant Strategy Induces Cardiac Allograft Unresponsiveness in High Responder Rats.  Jour Surg Research 1996; 63: 86-92.

37. Kuo PC, Alfrey EJ, Krieger NR, Abe KY, Huie P, Sibley RK, Dafoe DC. Differential Cellular Localization of Allograft Nitric Oxide Synthesis. Immunology  1996; 86:  647-653.

38. Johnson LB, Kuo PC, Dafoe DC, Drachenberg CB, Schweitzer EJ, Alfrey EJ, Ridge LA, Salvatierra P, Papadimitriou JC, Mergner WJ, Bartlett ST. The Use of Bilateral Adult Renal Allografts: A Method to Optimize Function from Donor Kidneys with Suboptimal Nephron Mass. Transplantation, 1996; 61: 1261-1263.

39. Kuo PC, Peterson J, Semba C, Alfrey EJ, Dafoe DC. CO2 angiography - a technique for vascular imaging in renal allograft dysfunction. Transplantation 1996; 61: 652-654.

40. Krieger NR, Holm B, Huie P, Bromberg JS, Most D, Sibley RK, Dafoe DC, Alfrey EJ. Coexistence of Th1 and Th2 Type Cytokine Profiles in Anti-CD2 Mediated Antibody Induced Tolerance. Transplantation 1996; 62: 1285-1292.

41. Johnson LB, Kuo PC, Dafoe DC, Drachenberg CB, Schweitzer EJ, Alfrey EJ, Klassen DK, Hoehn-Saric EW, Weir MR, Bartlett ST. Double Adult Renal Allografts: A technique for Expansion of the Cadaveric Kidney Donor Pool. Surgery 1996; 120: 580-584.

42. Kuo PC, Marks WH, Lieberman J, Johnson D, Alfrey EJ, Dafoe DC.Systemic Inflammatory Response Syndrome after Human Syngeneic Intestinal Transplantation: Evidence for Disruption of Enterocyte Barrier Function.  Transplant Proc 1996; 28: 2763-2764.

43. Morris JA, Johnson DL, Rimmer JAP, Kuo PC, Alfrey EJ, Bastidas JA, Dafoe DC. Identical Twin Small Bowel Transplant after Resection of Abdominal Desmoid Tumor. Transplant Proc. 1996; 28: 2732-2732.

44. Kuo PC, Johnson LB, Schweitzer EJ, Alfrey EJ, Waskerwitz J, Bartlett ST. Utilization of the Older Donor for Renal Transplantation. Am Jour Surg 1996; 172: 551-557.

45. Kuo PC, Morris J, Marks WH, Lieberman JM, Johnson DL, Alfrey EJ, Bastidas JA, Dafoe DC. Human Syngeneic Intestinal Transplantation: Evaluation of Enterocyte Viability with Serum Levels of Intestinal Fatty Acid Binding Protein. Clinical Transplantation 1996; 10:282-286.

46. Lee CM, Scandling JD, Shen GK, Salvatierra O, Dafoe DC, Alfrey EJ. The Kidneys that Nobody Wanted: Support for the Utilization of Expanded Criteria Donors.Transplantation  1996; 62: 1832-1841.

47. Kuo PC, Schroeder RA, Vagelos RH, Valentine H, Garcia G, Alfrey EJ, Haddow G, Dafoe DC. Volume-Mediated Pulmonary Responses in Liver Transplant Candidates. Clin Trans 1996; 10: 521-527.

48. Alfrey EJ, Conley SB, Tanney DC, Mak R, Scandling JD, Dafoe DC, Hammer GB, Orlandi PD, Page L, Salvatierra O. Use of an Augmented Urinary Bladder Can Be Catastrophic in Renal Transplantation. Transplant Proc 1997; 29: 154-155.

49. Salvatierra O., Jr., Tanney D, Mak R, Alfrey EJ, Lemley, Mackie F, So S, Hammer GB, Krane E, Conley SB.  Pediatric Renal Transplantation and Its Challenges.  Transplantation Reviews 1997; 11: 51-69.

50. Adams GA, Squires EC, Maestri M, Lee L, Alfrey EJ, Dafoe DC. Regimens of IGF-1 Treatment in Fetal Pancreas Transplantation. Jour Surg Research 1997; 68: 73-78.

51. Alfrey EJ, Conley SB, Tanney DC, Mak R, Scandling JD, Dafoe DC, Hammer GB, Orlandi PD, Page L, Salvatierra O. Bladder Augmentation Can Be Problematic With Renal Failure and Transplantation: Report of 10 Cases. Pediatric Nephrology  1997; 11:672-675.

52. Shen GK, Alfrey EJ, Knoppel CK, Dafoe DC, Scandling JD. Eradication of Cytomegalovirus Reactivation Disease Using High Dose Acyclovir and Targeted Intravenous Ganciclovir in Kidney and Pancreas Transplantation. Transplantation 1997; 64: 931-933.

53. Alfrey EJ, Lee CM, Scandling JD, Pavlakis M, Dafoe DC. When Should Expanded Criteria Donor Kidneys be used for Single Versus Dual Kidney Transplants? Transplantation 1997; 64: 1142-1146.

54. Salvatierra O, Alfrey EJ, Tanney DC, Mak R, Hammer GB, Krane EJ, SO SKS, Lemley K, Orlandi PD, Conley SB. Superior Outcomes in Pediatric Renal Transplantation. Arch Surg.  1997; 132: 842-849.

55. Lee CM, Scandling JD, Krieger NR, Dafoe DC, Alfrey EJ. Outcomes in Diabetic Patients After Simultaneous Pancreas-Kidney versus Kidney Alone Transplantation. Transplantation 1997; 64: 1288-1294.

56. Alfrey EJ, Lee CM, Scandling JD, Witter MM, Carter JT, Markezich AJ, Salvatierra O, Dafoe DC. Expanded Criteria Donor Kidneys: An Update on Outcome in Single versus Dual Kidney Transplants.Transplant Proc. 1997; 29: 3675-3677.

57. Lee CM, Scandling JD, Pavlakis M, Amy J. Markezich, Dafoe DC, Alfrey EJ. A Review of the Kidneys That Nobody Wanted: Determinants of Optimal Outcome. Transplantation 1998; 65: 213-219.

58. Adams GA, Maestri M, Squires EC, Alfrey EJ, Starzl TE, Dafoe DC. Augmenter of Liver Regeneration Enhances Fetal Pancreas Transplantation in Rodents. Transplantation 1998; 65: 32-36.

59. Fervenza FC, Lafayette RA, Alfrey EJ, Petersen J. Renal Artery Stenosis in Kidney Transplants. Am J Kidney Dis 1998; 31: 142-148.

60. Shen GK, Salvatierra O, Dafoe DC, Alfrey EJ. Use of Split Horseshoe Kidney for Transplantation. Surgery 1998; 123:475-477.

61. Lee CM, Markezich AJ, Scandling JD, Dafoe DC, Alfrey EJ. Cyclosporine A and Mycophenolate Mofetil is the Superior Treatment Strategy in Cadaveric Renal Transplantation.Jour Surg Research 1998; 76;131-136.

62. Desai DM, Scandling JD, Knoppel C, Dafoe DC, Alfrey EJ. Low Dose OKT3 Treatment for Rejection/Induction in Kidney and Kidney/Pancreas Transplantation. Transplant Proc 1998: 30: 1552-1554.

63. Maestri M, Krieger N, Kuo P, Dafoe DC, Alfrey EJ. Kidney-pancreas transplantation. Clinical results in 23 patients. Minerva Chir 1998; 53:121-128.

64. Kwon O, Nelson WJ, Sibley RJ, Huie P, Scandling JD, Dafoe DC, Alfrey EJ, Myers BD. Backleak, tight junctions, and cell-cell adhesion in postischemic injury to the renal allograft. J Clin Invest 1998;101:2054-2064.

65. Dafoe DC, Alfrey EJ. The Expanded Donor Kidney: The Stanford Experience with Dual Renal Grafts. Graft 1998; 1: 11-12.

66. Salvatierra O, Singh T, Shifrin R, Conley S, Alexander S, Tanney D, Lemley K, Sarwal M, Mackie F, Alfrey E, Orlandi P, Zarins C, Herfkens R. Successful Transplantation of Adult Sized Kidneys into Infants Requires Maintenance of High Aortic Blood Flow.Transplantation 1998; 66: 819-823.

67. Kwon O, Myers BD, Sibley RK, Dafoe DC, Alfrey EJ, Nelson WJ. Distribution of Cell Membrane Associated Proteins Along the Human Nephron. Histochemistry and Cytochemistry 1998; 46: 1423-1434.

68. Dafoe DC, Alfrey EJ. Dual renal allografts: expansion of the donor pool from an overlooked source. Transpl Int 1998; 11:164-168.

69. Kwon O, Corrigan G, Myers BD, Sibley RK, Scandling JD, Dafoe DC, Alfrey EJ, Nelson WJ Sodium resorption and distribution of Na+/K+ ATPase during postischemic injury to the renal allograft. Kidney International 1999; 55: 963-975.
70. Salvatierra O, Singh T, Shifrin R, Conley S, Alexander S, Tanney D, Lemley K, Sarwal M, Mackie F, Alfrey E, Orlandi P, Zarins C, Herfkens R. Transplantation of Adult-sized Kidneys into Infants Induces Major Blood Flow Changes. Transplant Proc 1999; 31: 236-237.

71. Sidhu MK, Gambhir S, Jeffrey RB, Sommer FG, Li KCP, Krieger NK, Alfrey EJ, Scandling JD. Power Doppler Imaging (PDI) of Acute Renal Transplant Rejection. JCU 1999 27; 171-175.

72. Lee CM, Carter JT, Weinstein R, Pease H, Scandling JD, Pavlakis M, Dafoe DC, Alfrey EJ. Dual Kidney Transplants: Older Donors for Older Recipients. JACS 1999; 189:82-92.

73. Lu AD, Carter JT, Weinstein RJ, Prapong W, Salvatierra O, Dafoe DC, Alfrey EJ. Excellent Outcome in Recipients of Dual Kidney Transplants: A Report of the First Fifty Dual Kidney Transplants at Stanford University. Arch Surg 1999; 134: 971-976.

74. Desai DM, Adams GA, Wang X, Alfrey EJ, Sibley RK, Dafoe DC. The Influence of Combined Trophic Factors on the Success of Fetal Pancreas Grafts. Transplantation 1999; 68: 491-496.

75. Salvatierra O, Sarwal M, Alexander S, Lemley K, Yorgin P, Al-Uzri A, Lu A, Millan M, Alfrey E. A New, Unique and Simple Method for Ureteral Implantation in Kidney Recipients with Small, Defunctionalized Bladders. Transplantation 1999; 68:731-738.

76. Corrigan G, Ramaswamy D, Kwon O, Sommer FG, Alfrey EJ, Dafoe DC, Olshen RA, Scandling JD, Myers BD. PAH Extraction and Estimation of Plasma Flow in Human Post- Ischemic Acute Renal Failure: A Study of the Renal Allograft. Am Jour Physiology  1999; 277: 312-318.

77. Lu AD, Carter JT, Weinstein RJ, Stratta RJ, Taylor RJ, Bowers VD, Ratner L, Chavin KD, Johnson LB, Kuo PC, Cole EH, Dafoe DC, Alfrey EJ. Outcome in Recipients of Dual Kidney Transplants: An Analysis of the Dual Registry Patients.Transplantation 2000; 69:281-285.

78. Lee CM, Carter JT, Randall HB, Hirose R, Stock PG, Melzer JS, Dafoe DC, Freise CE, Alfrey EJ. The Effect of Age and Prolonged Cold Ischemia Times on the National Allocation of Cadaveric Renal Allografts. Jour Surg Research 2000; 91: 83-88.

79. Carter JT, Lee CM, Weinstein RJ, Lu AD, Dafoe DC, Alfrey EJ. Evaluation of the Older Cadaveric Kidney Donor: The Impact of Hypertension and Creatinine Clearance on Graft Performance and Survival. Transplantation 2000; 70: 765-771.

80. Lee CM, Carter JT, Alfrey EJ, Ascher NL, Roberts JP, Freise CE. Prolonged Cold Ischemia Time Obviates the Benefits of 0 HLA Mismatches in Renal Transplantation. Arch Surg 2000; 135.

81. Lu AD, Dev Desai, Myers BD, Dafoe DC, Alfrey EJ. Severe Glomerular Sclerosis is not Associated with Poor Outcome after Kidney Transplantation. Am Jour Surg 2001; 180: 470-474.

82. Lu AD, Dev Desai, Myers BD, Dafoe DC, Alfrey EJ. Excellent Outcome Despite Adverse Histology After Cadaveric Kidney Transplantation. Transplant Proc 2001; 33: 1148.

83. Alfrey EJ, Lu AD, Carter JT, Dafoe DC. Matching Does not Improve Outcome from Aged Marginal Kidney Donors. Transplant Proc 2001; 33: 1162.

84. Alfrey EJ, Lu AD, Carter JT, Bowers, V, Taylor R, Ratner L, Cole E, Schweitzer E, Krishnamurti V, Tan H, Stratta R. The Dual Kidney Transplant Registry. Transplant Proc 2001; 33: 1099.

85. Hollenbeak C.S., Alfrey EJ, Souba WW. The Effect of Surgical Site Infection on Outcomes and Resource Utilization After Liver Transplantation. Surgery 2001; 130: 388.

86. Ramaswamy D, Corrigan G, Polhemus C, Boothroyd D, Scandling J, Sommer FG, Alfrey E, Higgins J, Deen WM, Olshen R, Myers BD. Maintenance and Recovery Stages of Postischemic Acute Renal Failure in Humans. Am J Physiol-Renal Physiol 2002; 282: 271-280.

87. Rosengard BR, Feng S, Alfrey EJ, Zaroff JG, Emond JC, Henry ML, Garrity ER, Roberts JP, Wynn JJ, Metzger RA, Freeman RB, Port FK, Merion RM, Love RB, Busuttil RW, Delmonico FL. Report of the Crystal City Meeting to Maximize the Use of Organs Recovered from the Cadaveric Donor. Am Jour Transplantation 2002; 2: 701-711.

88. Alfrey EJ, Boissy AR, Lerner SL. Dual Kidney Transplants: Long-Term Results. Transplantation 2003; 75: 1232-1236.

89. Gonwa T, Johnson C, Ahsan N, Alfrey EJ, Halloran P, Stegall M, Hardy M, Metzger R, Shield C, Rocher L, Scandling J, Sorensen J, Mulloy L, Light J, Corwin C, Danovich G, Wachs M, VanVeldhuisen P, Leonhardt M, Fitzsimmons WE. Randomized Trial of Tacrolimus + Mycophenolate Mofetil or Azathioprine versus Cyclosporine + Mycophenolate Mofetil after Cadaveric Kidney Transplantation: Results at Three Years. Transplantation 2003; 75: 2048-2053.

90. Kaufman DB, Burke GW, Bruce DS, Johnson CP, Gaber AO, Sutherland DER, Merion RM, Gruber SA, Schweitzer E, Leone JP, Marsh CL, Alfrey E, Conception W, Stegall MD, Schulak JA, Gores PF, Benedetti E, Smith C, Henning AK, Kuehnel F, King S, Fitzsimmons WE. A Prospective, Randomized, Multi-Center Trial of Antibody Induction Therapy in Simultaneous Pancreas-Kidney Transplantation. Am Jour Transplantation (In Press)

91. Hollenbeak CS,  Alfrey EJ, Sheridan K, Burger TL, Dillon PW. Surgical Site Infections Following Pediatric Liver Transplantation: Risks and Costs. Transplant Infect Dis 2003; 5: 72-78.

92. Saleem TFM, Cunningham KE, Hollenbeak CS, Alfrey EJ, Gabbay RA. Development of Diabetes Mellitus Post-Renal Transplantation is Associated with Poor Short-Term Clinical Outcomes. Transplant Proc 2003; 35:

93. Tan JC, Alfrey EJ, Dafoe DC, Millan MT, Scandling JD. Dual-Kidney Transplantation using Organs from Expanded Criteria Donors: A Long-Term Follow-Up. Transplantation 2004; 78: 692-696.

94. Dick AA  Lerner SM, Boissy AFarrell CE, Alfrey EJ. Excellent Outcome in Infants and Small Children with Thrombophilias Undergoing Kidney Transplantation. Pediatric Transplantation 2005; 9: 39-42.

95. Pagano CR, Dawson L, Dick A, Lerner SM, Valenia T, Braun J, Farrell C, Alfrey EJ. No Increase in Rejection or Graft Loss in Kidney Transplant Recipients with Thrombophilia Treated With Anticoagulation and Triple Immunosuppression. Transplant Proc. 2005; 37:1902-1905.

96. Momen A, Bower D, Leuenberger UA, Boehmer J, Lerner SM, Alfrey EJ, Handly B, Sinoway L. Renal Vascular Response to Static Handgrip Exercise. Am J Physiol, Heart Circ Physiol 2005 .

Abstracts:

1. Wang X, Lee L, Adams GA, Alfrey EJ, Dafoe DC. Insulin-Like Growth Factor-1 (IGF-1) Results in Successful Fetal Pancreas (FP) Transplantation in the Intramuscular (IM) Site.  Surgical Forum; 1993; XLIV: 442-444.

2. Alfrey EJ, Wang X, Holm B, Dafoe DC. Tolerance to Liver But Not Heart Allografts after Intrathymic (IT) Inoculation of Donor Antigen. Hepatology 1993; 18: 60A.

3. Adams GA, Wang X, Lee L, Alfrey EJ, Dafoe DC.  Insulin Like Growth Factor-I (IFG-I) Enhances Reversal of Diabetes by Fetal Pancreas Isografts (FP).  Cell Transplantation 1994; 3: 217.

4. Kuo PC, Vagelos RH, Alfrey EJ, Garcia G, Dafoe DC. Liver Transplant Candidates Exhibit Volume Mediated Pulmonary Hypertension. Hepatology 1994; 20: 125A.

5. Krieger NR, Yamaguchi A, Huie P, Sibley RK, Dafoe DC, Alfrey EJ. Predominance of IL-4 mRNA Expression Early After Experimental Liver Transplantation (OLT). Hepatology 1995; 22; 216A.

6. Kuo PC, Alfrey EJ, Krieger NR, Huie P, Sibley RK, Dafoe DC. Differential Cellular Localization of Inducible Nitric Oxide Synthase mRNA in Acute Rejection of Vascularized Allografts. Surgical Forum 1995; XLVI: 400-402.

7. Tse E, Vinot O, Huie P, Sibley RK, Wang BY, Cooke JP, Dafoe D, Alfrey E, Scandling J, Myers BD. Vasodilator Unresponsiveness of Acute Postischemic Renal Allograft Failure.  JASN 1995; 6: 478.

8. Diekman-Guiroy B, Scandling JD, Busse-Henry S, Kuo PC, Dafoe DC, Alfrey EJ.Low Dose OKT3 Treatment for Induction/Rejection in Multi-organ Transplantation. JASN 1995; 6: 1080.

9. Alfrey EJ, Desai D, Lee CM, Millan M, Prapong W, Scandling JD, Pavlakis M, Dafoe DC. Severe Glomerular Sclerosis is not Associated with an Increase in Graft Loss after Cadaveric Renal Transplantation.Pediatric Transplantation 1998; 2: 46.

10. Are Two Kidneys Better Than One: Outcome in Single vs Pediatric En Bloc and Dual Kidney Transplants. Lee CM, Prapong P, Carter JT, Scandling JD, Pavlakis M, Dafoe DC, Alfrey EJ. Pediatric Transplantation 1998; 2: 71.

11. Outcome in Recipients of Dual Kidney Transplants: Analysis of the First 100 Registry Patients. Lu AD, Carter JT, Kuo PC, Johnson LB, Taylor R, Stratta R, Chavin K, Ratner L, Bowers VD, Alfrey EJ. Transplantation 1999: 67; S561.

12. Evaluation of the Older Cadaveric Kidney Donor: The Impact of Donor Hypertension on Graft Performance and Survival. Carter JT, Lee CM, Weinstein RJ, Lu AD, Dafoe DC, Alfrey EJ. Transplantation 1999: 67; S552.

13. A Two Dose Regimen of Daclizumab (Zenapax) in High-Risk Renal Transplant Recipients. Millan M, Pavlakis M, Alfrey E, Salvatierra O, Dafoe D, Scandling J. Transplantation 1999: 67; S84.

14. Utilization of Kidneys from Older Cadaveric Donors: Older Recipients Should Receive Older Donor Kidneys. Lee CM, Prapong W, Scandling JD, Pavpakis M, Dafoe DC, Alfrey EJ. Transplantation 1999: 67; S92. 

15. Outcome in Older Patients with Delayed Graft Function (DGF) after Cadaveric Renal Transplantation (CRT): Greater Age does not Decrease Graft Survival in Pateints with DGF. Lee CM, Prapong W, Scandling JD, Pavpakis M, Dafoe DC, Alfrey EJ. Transplantation 1999: 67; S165.

16. Estimated Donor Creatinine Clearance Predicts Graft Survival and Initial Function in Recipients of Older Cadaveric Renal Transplants. Carter JT, Lee CM, Lu AD, Weinstein RJ, Pease HM, Currie CE, Dafoe DC, Alfrey EJ. Transplantation 1999: 67; S237.

Book Chapters:

1. Dafoe DC, Alfrey EJ.  Urologic Aspects of Renal Transplantation. In Hanno PM, Wein AJ. (Eds.) Clinical Manual of Urology, 2nd ed. McGraw-Hill 1994: 681-694.

2. Alfrey EJ, Dafoe DC.  Liver/Kidney Transplantation.  In Jaffe, R.A., Samuels, S.I. (Eds.) Anesthesiologist?s Manual of Surgical Procedures, 1st. ed., Raven, 1994: 429-451.

3. Dafoe DC, Alfrey EJ. Pancreas and Islet Transplantation. In Zuidema GD (Ed.) Shackelford?s Surgery of the Alimentary Tract, 4th ed. W.B. Saunders, 1996: 160-163.

4.Alfrey EJ, Morris RE. Transplant Immunopharmacology. In Neiderhuber JE. (Ed.) Fundamentals of Surgery, 1st ed. Appleton-Lange 1997; 618-623.

5. Krieger NR, Fathman CG, Alfrey EJ. Transplant Immumology. In Neiderhuber JE. (Ed.) Fundamentals of Surgery, 1st ed. Appleton-Lange 1997; 621-617.

6. Alfrey EJ. Kidney Transplantation Surgery. In Jamison RL and Wilkinson R. (Ed.) Nephrology, 1st. ed. Chapman and Hall 1997; 1083-1085.

7. Kuo PC, Alfrey EJ, Dafoe DC. The Pretransplant Selection and Evaluation of Donor and Recipient. In Jamison RL and Wilkinson R. (Ed.) Nephrology, 1st. ed. Chapman and Hall 1997; 1072-1082.

8. Desai DM, Scandling JD, Alfrey EJ, Pavlakis M, Salvatierra O, Conley S, Tanney D, Dafoe DC. Kidney and Kidney/Pancreas Transplantation at Stanford University Medical Center. In Cecka and Terasaki  (Ed.) Clinical Transplants 1997; 135-147.

9. Alfrey EJ, Lerner SM, Lu AD. The Dual Kidney Transplant Registry. In Cecka and Terasaki (Ed.) Clinical Transplants 2001; 107-111.

Letters to the Editor:

1.    Kuo PC, Mell D, Alfrey EJ, Scandling J, Dafoe DC. Pharmaceutical Expenses After Kidney and Kidney-Pancreas Transplantation. Transplantation  1995: 59; 452-453.

2.   Identical-Twin Small-Bowel Transplant for Desmoid Tumor. Jonathan A Morris, Denise L Johnson, John A P Rimmer, Paul C Kuo, Edward J Alfrey, J Augusto Bastidas, Donald C Dafoe. Lancet 1995: 345; 1577-1578.
 
Department Home : Cardiothoracic : Clerkship : Cosmetic Center : Emergency Medicine : General Surgery : Hand Therapy : HANOT
Hearing and Balance : Neurosurgery : Otolaryngology : Orthopaedics : Plastic Surgery : Surgical Skills Lab : Urology
Vascular Surgery : The Breast Center : The Prostate Center : The Voice Clinic : The Trauma Center : Site Map : SIU SOM